Ovid Therapeutics (OVID) reported a third-quarter 2026 net loss of $20.8 million, or $0.10 per basic and diluted common share, compared with a $12.2 million loss, or $0.17 per share, a year earlier.
Cash, cash equivalents and marketable securities totaled $161.4 million at Sept. 30, 2026. The company said its financial runway is expected to extend into 2029 as it advances OV329 and OV4071 clinical programs.
- Third-quarter research and development expense was $15.7 million, versus $5.9 million in the prior-year period.
- Total operating expenses were $22.4 million, compared with $12.7 million a year earlier.
- OV329’s Phase 2 focal epilepsy study is expected to complete in the second half of 2027; photosensitivity-study topline data are expected in the first quarter of 2027.
- OV4071 Phase 1 topline results and ketamine challenge study results are expected in the first quarter of 2027.
- Ovid plans to initiate a TSC-associated seizures study of pediatric OV329 in the fourth quarter of 2026.
$OVID Hedge Fund Activity
We have seen 72 institutional investors add shares of $OVID stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 9,290,197 shares (+605.9%) to their portfolio in Q2 2026, for an estimated $24,990,629
- BRAIDWELL LP added 5,919,464 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,923,358
- SATURN V CAPITAL MANAGEMENT LP removed 3,503,606 shares (-84.1%) from their portfolio in Q2 2026, for an estimated $9,424,700
- ADAR1 CAPITAL MANAGEMENT, LLC added 2,873,366 shares (+63.2%) to their portfolio in Q2 2026, for an estimated $7,729,354
- STEMPOINT CAPITAL LP added 2,417,283 shares (+inf%) to their portfolio in Q2 2026, for an estimated $6,502,491
- FEDERATED HERMES, INC. added 2,380,666 shares (+66.7%) to their portfolio in Q2 2026, for an estimated $6,403,991
- ALLY BRIDGE GROUP (NY) LLC removed 2,193,898 shares (-77.8%) from their portfolio in Q2 2026, for an estimated $5,901,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
